Get the Stockscreener App
5.77
3.50%
0.195
After Hours:
5.70
-0.07
-1.21%
Lifemd Inc Stock (LFMD) Latest News
LifeMD stock target raised to $14 by H.C. Wainwright - Investing.com India
LifeMD Full Year 2024 Earnings: Beats Expectations - Yahoo Finance
LifeMD’s (LFMD) “Overweight” Rating Reaffirmed at Cantor Fitzgerald - Defense World
Cantor Fitzgerald maintains LifeMD stock at Overweight, $15 target By Investing.com - Investing.com Australia
LifeMD, Inc. Reports Strong Telehealth Growth Amid Challenges - TipRanks
LifeMD, Inc. SEC 10-K Report - TradingView
LifeMD Inc. (LFMD) reports earnings - Quartz
LifeMD, Inc. (NASDAQ:LFMD) Q4 2024 Earnings Call Transcript - Insider Monkey
Top Premarket Gainers -March 11, 2025 at 07:54 am EDT - Marketscreener.com
KeyBanc maintains Overweight rating on LifeMD shares By Investing.com - Investing.com South Africa
KeyBanc maintains Overweight rating on LifeMD shares - Investing.com
LifeMD Inc (LFMD) Q4 2024 Earnings Call Highlights: Robust Revenue Growth and Strategic Expansions - Yahoo Finance
LifeMD Inc (LFMD) Q4 2024 Earnings Call Highlights: Robust Reven - GuruFocus.com
Earnings call transcript: LifeMD beats Q4 2024 expectations, stock surges By Investing.com - Investing.com Canada
LifeMD, Inc. Reports Strong Q4 2024 Results - TipRanks
LifeMD Inc reports results for the quarter ended December 31Earnings Summary - TradingView
LifeMD reports Q4 EPS 21c vs. 14c last year - TipRanks
LifeMD Inc Outlook Q1 2025 Total Revenue In The Range Of $61 Million To $63 Million - Marketscreener.com
Earnings call transcript: LifeMD beats Q4 2024 expectations, stock surges - Investing.com
LifeMD Q4 Revenue USD 64.3 Million Versus. Ibes Estimate USD 57.4 Million -March 10, 2025 at 05:31 pm EDT - Marketscreener.com
LifeMD, Inc. (LFMD) Reports Q4 Loss, Tops Revenue Estimates - Yahoo Finance
LifeMD Reports Fourth Quarter 2024 Results - GlobeNewswire
LifeMD earnings beat by $0.26, revenue topped estimates - Investing.com Canada
LifeMD Reports Fourth Quarter 2024 Results - GlobeNewswire Inc.
LIFEMD Earnings Results: $LFMD Reports Quarterly Earnings - Nasdaq
LifeMD stock soars 16% on earnings beat, strong guidance By Investing.com - Investing.com Canada
LifeMD stock soars 16% on earnings beat, strong guidance - Investing.com India
LifeMD options imply 11.7% move in share price post-earnings - TipRanks
When Would Be The Best Time To Buy LifeMD Inc (NASDAQ: LFMD) Stock? - Stocks Register
LifeMD, Inc. (NASDAQ:LFMD) Receives $11.14 Average PT from Brokerages - Defense World
Rhumbline Advisers Raises Stock Position in LifeMD, Inc. (NASDAQ:LFMD) - Defense World
It's Down 27% But LifeMD, Inc. (NASDAQ:LFMD) Could Be Riskier Than It Looks - Simply Wall St
LifeMD Inc expected to post a loss of 5 cents a shareEarnings Preview - TradingView
LifeMD, Inc. (LFMD): A Bull Case Theory - MSN
LifeMD Inc (LFMD) Q4 2024: Everything You Need to Know Ahead of Earnings - GuruFocus.com
Teladoc, LifeMD tie up with Lilly's pharmacy partner to offer Zepbound - MSN
LifeMD and Teladoc Health partner with LillyDirect pharmacy provider Gifthealth for Zepbound - MSN
Two telehealth firms turn to branded Zepbound as restrictions loom on copies - Reuters
Teladoc, LifeMD partner with Eli Lilly on GLP-1s - Modern Healthcare
LifeMD announces integration with LillyDirect pharmacy provider - TipRanks
Teladoc, LifeMD tie up with Lilly's pharmacy partner to offer Zepbound -March 06, 2025 at 09:14 am EST - Marketscreener.com
LifeMD Integrates With LillyDirect to Offer Access of Single-dose Vials of Zepbound - MarketWatch
Telehealth firms Teladoc, LifeMD tie up with Eli Lilly's pharmacy partner to offer Zepbound - Marketscreener.com
LifeMD to Offer Zepbound Through LillyDirect Partnership -March 06, 2025 at 08:43 am EST - Marketscreener.com
LifeMD integrates with Gifthealth for obesity treatment access - Investing.com India
LifeMD® Announces Integration with LillyDirect Pharmacy - GlobeNewswire
Can LifeMD's New Lilly Partnership Transform Patient Access to Zepbound? - StockTitan
LifeMD to Participate in the KeyBanc Capital Markets Healthcare Forum - GlobeNewswire
Can LifeMD's Upcoming Investor Presentation Reveal New Growth Strategies? - StockTitan
LifeMD (LFMD) to Release Earnings on Monday - Defense World
Kaskela Law LLC Announces Important Deadline in Shareholder Class Action Lawsuit Against LifeMD, Inc. (LFMD) and Encourages Investors with Losses in Excess of $250,000 to Contact the Firm - ACCESS Newswire
1.01%
0.22%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):